Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP504800.RAyjC-nT-iRHOfyG0NtrFDHUiHf639O_ana-ElQDXgLvA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP504800.RAyjC-nT-iRHOfyG0NtrFDHUiHf639O_ana-ElQDXgLvA130_assertion type Assertion NP504800.RAyjC-nT-iRHOfyG0NtrFDHUiHf639O_ana-ElQDXgLvA130_head.
- NP504800.RAyjC-nT-iRHOfyG0NtrFDHUiHf639O_ana-ElQDXgLvA130_assertion description "[We determined the concentration of CXCL13 and IL-10 in CSF of CNS lymphoma patients and control cohorts including inflammatory and degenerative neurologic disease in a multicenter study involving 220 patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP504800.RAyjC-nT-iRHOfyG0NtrFDHUiHf639O_ana-ElQDXgLvA130_provenance.
- NP504800.RAyjC-nT-iRHOfyG0NtrFDHUiHf639O_ana-ElQDXgLvA130_assertion evidence source_evidence_literature NP504800.RAyjC-nT-iRHOfyG0NtrFDHUiHf639O_ana-ElQDXgLvA130_provenance.
- NP504800.RAyjC-nT-iRHOfyG0NtrFDHUiHf639O_ana-ElQDXgLvA130_assertion SIO_000772 23570798 NP504800.RAyjC-nT-iRHOfyG0NtrFDHUiHf639O_ana-ElQDXgLvA130_provenance.
- NP504800.RAyjC-nT-iRHOfyG0NtrFDHUiHf639O_ana-ElQDXgLvA130_assertion wasDerivedFrom befree-20150227 NP504800.RAyjC-nT-iRHOfyG0NtrFDHUiHf639O_ana-ElQDXgLvA130_provenance.
- NP504800.RAyjC-nT-iRHOfyG0NtrFDHUiHf639O_ana-ElQDXgLvA130_assertion wasGeneratedBy ECO_0000203 NP504800.RAyjC-nT-iRHOfyG0NtrFDHUiHf639O_ana-ElQDXgLvA130_provenance.